Endoscopic Vessel Harvesting System Market (2026 - 2033)

Endoscopic Vessel Harvesting System Market Summary

The global endoscopic vessel harvesting system market size was valued at USD 164.8 million in 2025 and is projected to grow from USD 170.5 million in 2026 to USD 217.0 million in 2033, at a CAGR of 3.5% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.0% of revenue in 2025. The increasing prevalence of cardiovascular diseases globally, such as peripheral artery disease & coronary artery disease, and growing preference for minimally invasive harvesting procedures are key factors driving the market.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Cardiovascular diseases remain the leading cause of mortality worldwide. According to the estimates published by the World Health Organization (WHO) in July 2025, around 19.8 million people died from cardiovascular diseases in 2022, accounting for approximately 32% of all global deaths, with heart attacks and strokes representing the majority of these fatalities. The persistent burden of cardiovascular disorders continues to increase the demand for coronary artery bypass grafting (CABG) procedures and minimally invasive vessel harvesting technologies, thereby supporting the adoption of endoscopic vessel harvesting (EVH) systems.

In addition, the growing incidence of heart rhythm disorders, including atrial fibrillation (AFib), is driving the demand for innovative solutions, including EVH systems, to manage atherosclerosis and improve surgical outcomes. According to the American Heart Association (AHA), more than 5 million Americans currently live with atrial fibrillation, and this number is projected to exceed 12 million by 2030 due to population aging and increasing prevalence of risk factors such as hypertension, obesity, and diabetes. The increasing incidence of AFib and associated cardiovascular complications is expected to accelerate the demand for cardiac interventions and related harvesting technologies.

Furthermore, advancements in medical imaging technologies integrated into EVH devices have enabled surgeons to achieve improved visualization and procedural precision. Manufacturers are increasingly incorporating advanced imaging modalities, including near-infrared fluorescence imaging and high-definition endoscopic visualization technologies, into EVH systems to facilitate real-time vessel assessment, improve graft quality, and reduce the risk of vessel trauma during harvesting. These technological advancements contribute to improved outcomes in coronary artery bypass grafting procedures and are expected to support market growth over the forecast period.

Although advances in percutaneous coronary interventions have reduced the number of CABG procedures performed in certain patient populations, the growing adoption of endoscopic vessel harvesting (EVH) systems and the increasing preference for minimally invasive cardiac surgery continue to support market growth. EVH techniques reduce surgical trauma, lower the risk of wound complications, and promote faster postoperative recovery compared with conventional open vessel harvesting. Furthermore, evidence-based clinical recommendations and the continued emphasis on improving CABG outcomes are encouraging healthcare providers to adopt minimally invasive vessel-harvesting techniques, thereby supporting sustained demand for advanced EVH systems.

Moreover, the growing emphasis on evidence-based cardiac surgery practices continues to support the adoption of minimally invasive vessel harvesting techniques. The 2025 Clinical Practice Guideline, jointly issued by the Society of Thoracic Surgeons and the European Association for Cardio-Thoracic Surgery, reinforces recommendations for optimal conduit selection and harvesting techniques in coronary artery bypass grafting (CABG), highlighting strategies to improve graft quality, reduce postoperative complications, and enhance patient outcomes. These recommendations continue to encourage the adoption of endoscopic vessel harvesting systems in modern cardiac surgical practice.

Analyst Perspective

The global market is experiencing steady growth as healthcare providers increasingly adopt minimally invasive, precision-driven techniques to improve cardiovascular surgery outcomes. Market expansion is primarily driven by the rising prevalence of coronary artery disease, peripheral artery disease, and other cardiovascular disorders, which continue to increase demand for coronary artery bypass grafting (CABG) procedures and advanced vessel-harvesting technologies. Continuous technological advancements, including high-definition endoscopic visualization, enhanced energy delivery systems, and improved imaging capabilities, are enabling greater procedural accuracy, efficiency, and patient safety. However, the high cost of EVH systems, the need for specialized surgical training, and the growing use of alternative coronary revascularization approaches may restrain market growth. Nevertheless, ongoing product innovation, increasing investments in cardiovascular care infrastructure, the rising adoption of minimally invasive cardiac surgery, and strategic collaborations among medical device companies are expected to create significant growth opportunities over the forecast period.

Product Insights

The disposable segment held the largest market share in 2025. The growth is attributed to reduced risk of cross-contamination and infection, heightened awareness, and regulatory requirements regarding hospital-acquired infections. To improve patient safety and regulatory compliance, these single-use solutions ensure sterility for every surgery. Further simplifying hospital operations and reducing the workload for medical personnel, they eliminate the need for elaborate and expensive sterilization procedures for reusable equipment. The durability and lack of wear and degradation associated with reusable equipment contribute to the market attraction of disposable systems. In addition, manufacturers are increasingly introducing advanced single-use EVH technologies that improve procedural efficiency and patient outcomes. For instance, in June 2026, Getinge AB announced the launch of its VasoView Hemopro 3 Endoscopic Vessel Harvesting System, featuring a redesigned harvesting tool, enhanced visualization, improved energy control, and streamlined workflow to support minimally invasive vessel harvesting during CABG procedures. The launch reflects the industry's continued focus on advancing EVH technologies that improve procedural efficiency, graft quality, and patient outcomes.

The reusable segment is expected to register the fastest CAGR over the forecast period, driven by its cost-effectiveness, procedural efficiency, and growing adoption in minimally invasive cardiovascular surgeries. Reusable endoscopic vessel harvesting systems offer long-term economic advantages by reducing per-procedure costs while maintaining consistent clinical performance and improving patient outcomes. In addition, increasing hospital investments in cost-optimization initiatives and advanced surgical infrastructure are accelerating the adoption of reusable EVH systems, as healthcare providers seek durable, high-performance solutions that enhance operational efficiency and support high surgical volumes.

Application Insights

The coronary artery disease segment held the largest market share in 2025. The growth is owed to the rising need to diagnose and monitor patients with CAD efficiently and accurately. These devices are designed to help healthcare providers assess heart function, diagnose CAD, and determine the best treatment plan for individuals with this condition. By utilizing technologies such as ECGs, echocardiograms, stress tests, chest X-rays, and coronary angiography, CAD devices enable healthcare professionals to evaluate the heart's electrical activity, visualize its structure and function, measure heart rate under stress conditions, and directly visualize blockages in the coronary arteries.

The peripheral artery disease (PAD) segment is expected to register the fastest growth over the forecast period. The growth is driven by its ability to serve patients with compromised vascular health, making it ideal for harvesting vessels from such individuals. These devices are equipped with features that enable precise and efficient vessel harvesting, even in challenging anatomical conditions often encountered in patients with PAD. In addition, the rising global prevalence of PAD has increased demand for specialized devices that effectively address the unique needs of these patients during vessel harvesting procedures.

Regional Insights

The North America market dominated the market, accounting for a revenue share of 40.0% in 2025. This is due to its large market size and significant growth in the healthcare sector. Expansion of the endoscopic vessel harvesting system industry in this region is driven by the rising prevalence of chronic diseases, the rapid adoption of technological advancements, and the growing elderly population. In addition, the region benefits from strong adoption of minimally invasive cardiac procedures and the presence of advanced cardiovascular treatment centers that increasingly utilize endoscopic vessel harvesting technologies.

To learn more about this report, Download Free Sample Report

U.S. Endoscopic Vessel Harvesting System Market Trends

The endoscopic vessel harvesting system market in the U.S. held the largest share in North America in 2025, owing to an aging population. Moreover, the rising number of cases of AFib in the country is also contributing to market growth. Furthermore, increasing investments in minimally invasive cardiovascular procedures and the growing adoption of advanced surgical technologies are supporting market expansion. The presence of specialized cardiac surgery centers and favorable reimbursement frameworks is further encouraging the adoption of endoscopic vessel harvesting systems across the country.

Europe Endoscopic Vessel Harvesting System Market Trends

The endoscopic vessel harvesting system market in Europe is expected to witness lucrative growth over the forecast period. The growth is driven by the increasing emphasis on personalized and preventive healthcare. Furthermore, government initiatives to improve healthcare infrastructure and accessibility are boosting the market for endoscopic vessel harvesting systems in Europe. In addition, the region is witnessing increasing investments in advanced cardiovascular therapies and minimally invasive surgical technologies to improve patient outcomes and reduce procedural complications. For instance, in July 2025, Xeltis announced positive clinical data from its European Union trial evaluating XABG, its restorative coronary artery bypass conduit designed for coronary artery bypass grafting procedures. The positive results reflect the growing adoption of advanced technologies in coronary artery bypass surgery, supporting demand for complementary surgical technologies, including endoscopic vessel harvesting systems across Europe.

The UK endoscopic vessel harvesting system market is one of the region's major markets. The growth is attributed to favorable reimbursement policies and government initiatives aimed at improving cardiovascular care, which also play a crucial role in driving market expansion by facilitating patients’ access to advanced treatment options. Furthermore, the country is increasingly emphasizing the adoption of minimally invasive cardiac procedures and strengthening specialized cardiovascular treatment pathways to improve procedural efficiency and long-term patient outcomes.

The endoscopic vessel harvesting system market in Germany is projected to expand over the forecast period owing to a rapidly aging population, growing prevalence of cardiovascular issues, a sophisticated healthcare system, a highly qualified workforce, and high healthcare spending. Moreover, the increasing technological advancements in monitoring devices, supportive reimbursement policies, and strategic collaborations within the healthcare industry are further boosting market growth in the country. The country's strong focus on medical technology innovation and minimally invasive cardiovascular interventions continues to support demand for advanced vessel harvesting systems.

Asia Pacific Endoscopic Vessel Harvesting System Market Trends

The endoscopic vessel harvesting system market in the Asia Pacific is expected to grow at the fastest CAGR from 2026 to 2033. Factors such as unhealthy dietary habits and the rising adoption of a sedentary lifestyle leading to physical inactivity are contributing to increased cardiovascular morbidities in the region. Moreover, several multinational companies are setting up manufacturing operations in the region due to low manufacturing costs and the availability of skilled labor.

Japan endoscopic vessel harvesting system market is expected to grow at the fastest rate. The market is expected to expand steadily in the foreseeable future due to ongoing advances in cardiovascular technologies and strategic initiatives undertaken by key players in the country. Furthermore, companies are increasingly introducing minimally invasive, digitally enabled solutions to improve the diagnosis and treatment of coronary artery disease.

Latin America Endoscopic Vessel Harvesting System Market Trends

The endoscopic vessel harvesting system market in Latin America is experiencing significant growth, attributed to rising awareness of cardiovascular issues and treatments. Furthermore, improvements in healthcare infrastructure and increased access to advanced cardiac surgical procedures are encouraging the adoption of minimally invasive technologies. The region is also witnessing growing investments in specialized cardiovascular centers and physician training programs to enhance treatment outcomes.

Brazil endoscopic vessel harvesting system market is expected to grow over the forecast period due to the increasing number of minimally invasive surgeries and rising awareness of these procedures among healthcare professionals and patients. Moreover, the country's efforts to modernize hospital infrastructure and expand access to advanced cardiovascular care are creating favorable conditions for the adoption of endoscopic vessel harvesting technologies.

MEA Endoscopic Vessel Harvesting System Market Trends

The endoscopic vessel harvesting system market in MEA is experiencing significant growth. Rising awareness regarding minimally invasive cardiovascular procedures and increasing investments in healthcare infrastructure are further fueling market growth in the region. Furthermore, the region is witnessing greater adoption of advanced cardiac surgery technologies and increasing emphasis on improving cardiovascular treatment capabilities.

Saudi Arabia endoscopic vessel harvesting system market is expected to grow steadily during the forecast period, driven by rising cardiovascular procedures and a growing focus on minimally invasive surgical techniques. Moreover, government initiatives aimed at strengthening specialized healthcare services and expanding cardiovascular treatment capacities are supporting market development. Increasing investments under healthcare transformation programs are also facilitating the adoption of advanced surgical technologies in the country.

Key Endoscopic Vessel Harvesting System Company Insights

The market features a highly competitive landscape shaped by a mix of established medical device giants and specialized medical technology innovators. Following the trends highlighted in the industry overview, leading companies actively pursue strategic collaborations, mergers, acquisitions, and substantial R&D investments to sustain their market positions and meet the evolving demands of advanced cardiac surgery.

Key Endoscopic Vessel Harvesting System Companies

The following key companies have been profiled for this study on the endoscopic vessel harvesting system market:

• MAQUET Holding B.V. & Co. KG

• CARDIO MEDICAL GmbH

• Terumo Cardiovascular Group

• Med Europe S.r.l. (Elite Life Care)

• LivaNova plc. (Sorin and Cyberonics)

• Saphena Medical, Inc.

• Getinge AB

• Olympus Corporation

• Saphena Medical

• KARL STORZ

• Medical Instruments S.p.a

Recent Developments

• In June 2025, Terumo Corporation announced a distribution partnership with MedHub-AI to commercialize the AI-based AutocathFFR solution in Japan. The partnership expands Terumo's cardiovascular portfolio by integrating advanced technologies to assess coronary physiology, enhance diagnostic accuracy, and support informed treatment planning for patients with coronary artery disease.

• In May 2024, Getinge AB organized the Vessel Harvesting (EVH) Summit in Singapore. The panel discussions featured four clinicians sharing their perspectives on Endoscopic Vessel Harvesting (EVH), covering topics such as surgical ergonomics, patient considerations, emergency scenarios, and technical aspects, and concluded with insights and general advice from the panelists.

Endoscopic Vessel Harvesting System Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities across each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global endoscopic vessel harvesting system market report based on product, application, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Disposable

  • Re-usable

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Coronary Artery Disease (CAD)

  • Peripheral Artery Disease (PAD)

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Norway

    • Sweden

    • Denmark

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait